Rotavirus serotype G9 Is associated with more-severe disease in Latin America

Linhares, A. C.; Verstraeten, Thomas; Wolleswink-van den Bosh, Judith; Clemens, Ralf; Breuer, Thomas

Linhares, A. C.; Verstraeten, Thomas; Wolleswink-van den Bosh, Judith; Clemens, Ralf; Breuer, Thomas.

Afiliação

Linhares, A. C.; Instituto Evandro Chagas-SVS/MS. Belém. Brasil
Verstraeten, Thomas; GlaxoSmithKline Biologicals. Rio de Janeiro. Brasil
Wolleswink-van den Bosh, Judith; Pallas Health Research and Consultancy. Rotterdan. Netherlands
Clemens, Ralf; GlaxoSmithKline Biologicals. Rio de Janeiro. Brasil
Breuer, Thomas; GlaxoSmithKline Biologicals. Rio de Janeiro. Brasil

Clin Ifect Dis ; 43(3): 312-314, 2006. tab

Article em En | BVSDIP, FIOCRUZ | ID: dip-2002

Biblioteca responsável: BR275.1

Localização: BR275.1; PCIEC2006

ABSTRACT

ABSTRACT

The association between rotavirus serotypes and severity is not well established. Analysis of a clinical trial conducted in Latin America points at more-severe disease associated with serotype G9. Thus, demonstration of efficacy against G9 will be an important asset of any rotavirus vaccine to be introduced into a Latin American country or any country where G9 has been shown to be prevalent...(AU)

Assuntos

Animais; Masculino; Feminino; Rotavirus/classificação; Infecções por Rotavirus/epidemiologia; Gastroenterite; Vacinas contra Rotavirus/uso terapêutico

Texto completo

Imprimir

XML

Buscar no Google

Texto completo: 1 Base de dados: BVSDIP / FIOCRUZ Assunto principal: Infecções por Rotavirus / Rotavirus / Vacinas contra Rotavirus / Gastroenterite Limite: Animals Idioma: En Revista: Clin Ifect Dis Ano de publicação: 2006 Tipo de documento: Article

Texto completo

Imprimir

XML

Buscar no Google